ARTICLE | Clinical News
Trulicity dulaglutide: Phase III data
July 25, 2016 7:00 AM UTC
The double-blind, international Phase III AWARD-9 trial in 300 Type II diabetics showed that once-weekly 1.5 mg Trulicity as an add-on to Lantus insulin glargine met the primary endpoint of reducing ...